Why the study?
Does N-monomethyl L-arginine (L-NMMA) reduce blood flow responses during reactive hyperaemia in healthy human subjects?
Does N-monomethyl L-arginine (L-NMMA) reduce blood flow responses during reactive hyperaemia in healthy human subjects?
Nitric oxide production does not significantly contribute to vasodilatation during reactive hyperaemia in the human forearm.
Answers are grounded in this paper and cite their sources.
L-NMMA does not blunt reactive hyperaemia; challenges nitric oxide dependence and directs research toward alternative forearm vasodilator pathways.
AIMS: To determine the role of nitric oxide (NO) in forearm reactive hyperaemia in healthy human subjects. METHODS: Ten healthy subjects aged 19-34 years underwent brachial artery cannulation. Forearm circulatory arrest was achieved by means of an upper arm cuff inflated to 200 mmHg for 5 min. The blood flow responses during reactive hyperaemia were measured using venous occlusion plethysmography following a 10 min intra-arterial infusion of 8 micromol min-1 N-monomethyl L-arginine (L-NMMA) and following matching placebo administered in random order. Results were analysed by repeated measures anova and t-tests. RESULTS: L-NMMA resulted in a significant reduction of basal forearm blood flow indicating inhibition of basal NO release (P=0.005). There was no significant difference between the blood flow responses during reactive hyperaemia following L-NMMA and placebo (P=0.97). CONCLUSIONS: Nitric oxide production does not make a significant contribution to the vasodilatation associated with reactive hyperaemia in the human forearm.
No takes yet. Share an insight, caveat, or question.
Nugent et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: